CESCA THERAPEUTICS INC. (34) | Business Finance (15)

Browse by Subcategory

Recent Contracts

Payment Protection Program Loan (PPP Loan) between ThermoGenesis Holdings, Inc. and Comerica Bank dated April 21, 2020 (Filed With SEC on August 14, 2020)
Form of Stock Option Agreement (Filed With SEC on June 9, 2020)
Form of Securities Purchase Agreement, dated as of March 25, 2020, between ThermoGenesis Holdings, Inc. and the Purchasers identified on the signature pages thereto (Filed With SEC on March 27, 2020)
Contribution Agreement, dated November 22, 2019, between ThermoGenesis Holdings, Inc. and ImmuneCyte Life Sciences Inc (Filed With SEC on November 27, 2019)
Amendment No. 1, dated July 23, 2019, to the Convertible Promissory Note, dated January 29, 2019 between Cesca therapeutics Inc. and Orbrex USA Co (Filed With SEC on November 19, 2019)
Form of Pre-Funded Warrant (Filed With SEC on April 25, 2019)
Investors Rights Agreement, dated January 1, 2019, among CARTXpress Bio, Inc., Bay City Capital Fund V, L.P., and Bay City Capital Fund V Co-Investment Fund, L.P (Filed With SEC on January 4, 2019)
Form of Stock Option Award Agreement (Filed With SEC on January 3, 2020)
Amendment No. 1 to the Convertible Promissory Note, Dated July 23, 2019 between Cesca therapeutics Inc. and Orbrex USA Co (Filed With SEC on August 13, 2019)
Form of Note (Filed With SEC on July 29, 2019)
Securities Purchase Agreement, dated as of July 23, 2019, between Cesca Therapeutics Inc. and the Purchaser identified on the signature pages thereto (Filed With SEC on July 29, 2019)
Amendment No. 1 to the Convertible Note Agreement dated as of July 23, 2019, between Cesca Therapeutics Inc. and Orbrex USA Co (Filed With SEC on July 29, 2019)
Securities Purchase Agreement, dated as of April 18, 2019, between Cesca Therapeutics Inc. and the Purchaser identified on the signature pages thereto (Filed With SEC on April 25, 2019)
Form of Note (Filed With SEC on January 31, 2019)
Securities Purchase Agreement, dated as of January 29, 2019, between Cesca Therapeutics Inc. and the Purchasers identified on the signature pages thereto (Filed With SEC on January 31, 2019)